TERN Nilai Total Aset Perusahaan Terns Pharma
This chart of Terns Pharmaceuticals (TERN) share prices illustrates asset dynamics that currently stand at 694.66. Terns Pharmaceuticals (TERN) minimizes risks by developing a broad portfolio of small molecules for the therapy of metabolic disorders and gastrointestinal issues. The business focuses on replacing injections with convenient tablets for weight loss treatment. The company may transfer drug rights to major partners in the future.
Rincian analitis lan laporan data perusahaan Terns Pharmaceuticals Inc (TERN)
Total assets determine the aggregate value of the company's resources, expressing the fundamental base through a reverse calculation from the return on assets (ROA). The dynamics of total assets reflect Terns Pharmaceuticals' dependence on external financing, as the absence of commercial products makes the asset value critically sensitive to capital inflows required to conduct clinical trials for gastrointestinal disease therapies.